Logo image of SNYR

SYNERGY CHC CORP (SNYR) Stock Fundamental Analysis

NASDAQ:SNYR - Nasdaq - US87165D2080 - Common Stock - Currency: USD

2.1  +0.05 (+2.44%)

After market: 2.1 0 (0%)

Fundamental Rating

4

Taking everything into account, SNYR scores 4 out of 10 in our fundamental rating. SNYR was compared to 35 industry peers in the Personal Care Products industry. SNYR has a medium profitability rating, but doesn't score so well on its financial health evaluation. SNYR is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SNYR was profitable.
In the past year SNYR has reported a negative cash flow from operations.
In multiple years SNYR reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: SNYR reported negative operating cash flow in multiple years.
SNYR Yearly Net Income VS EBIT VS OCF VS FCFSNYR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2023 2024 0 5M -5M 10M

1.2 Ratios

The Return On Assets of SNYR (13.00%) is better than 85.71% of its industry peers.
With an excellent Return On Invested Capital value of 66.57%, SNYR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 13%
ROE N/A
ROIC 66.57%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNYR Yearly ROA, ROE, ROICSNYR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2023 2024 0 500 1K 1.5K 2K 2.5K

1.3 Margins

With a decent Profit Margin value of 6.10%, SNYR is doing good in the industry, outperforming 74.29% of the companies in the same industry.
SNYR's Operating Margin of 16.65% is fine compared to the rest of the industry. SNYR outperforms 80.00% of its industry peers.
SNYR's Operating Margin has improved in the last couple of years.
SNYR has a Gross Margin (67.87%) which is in line with its industry peers.
SNYR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.65%
PM (TTM) 6.1%
GM 67.87%
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
SNYR Yearly Profit, Operating, Gross MarginsSNYR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2023 2024 0 20 -20 40 -40 60

1

2. Health

2.1 Basic Checks

SNYR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for SNYR has been increased compared to 1 year ago.
Compared to 5 years ago, SNYR has more shares outstanding
The debt/assets ratio for SNYR has been reduced compared to a year ago.
SNYR Yearly Shares OutstandingSNYR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2023 2024 20M 40M 60M 80M
SNYR Yearly Total Debt VS Total AssetsSNYR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

SNYR has an Altman-Z score of -0.22. This is a bad value and indicates that SNYR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.22, SNYR is not doing good in the industry: 82.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.22
ROIC/WACC6.43
WACC10.36%
SNYR Yearly LT Debt VS Equity VS FCFSNYR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

SNYR has a Current Ratio of 0.93. This is a bad value and indicates that SNYR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.93, SNYR is doing worse than 74.29% of the companies in the same industry.
A Quick Ratio of 0.83 indicates that SNYR may have some problems paying its short term obligations.
The Quick ratio of SNYR (0.83) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.83
SNYR Yearly Current Assets VS Current LiabilitesSNYR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M

5

3. Growth

3.1 Past

The earnings per share for SNYR have decreased strongly by -67.60% in the last year.
The Revenue for SNYR has decreased by -18.57% in the past year. This is quite bad
Measured over the past years, SNYR shows a small growth in Revenue. The Revenue has been growing by 3.48% on average per year.
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.47%
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%-22.3%

3.2 Future

Based on estimates for the next years, SNYR will show a very strong growth in Earnings Per Share. The EPS will grow by 43.78% on average per year.
The Revenue is expected to grow by 20.11% on average over the next years. This is a very strong growth
EPS Next Y66.67%
EPS Next 2Y55.46%
EPS Next 3Y43.78%
EPS Next 5YN/A
Revenue Next Year36.46%
Revenue Next 2Y25.8%
Revenue Next 3Y20.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNYR Yearly Revenue VS EstimatesSNYR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2023 2024 2025 2026 2027 10M 20M 30M 40M
SNYR Yearly EPS VS EstimatesSNYR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

SNYR is valuated cheaply with a Price/Earnings ratio of 7.50.
Based on the Price/Earnings ratio, SNYR is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.03. SNYR is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 3.43, the valuation of SNYR can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SNYR indicates a rather cheap valuation: SNYR is cheaper than 97.14% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SNYR to the average of the S&P500 Index (21.94), we can say SNYR is valued rather cheaply.
Industry RankSector Rank
PE 7.5
Fwd PE 3.43
SNYR Price Earnings VS Forward Price EarningsSNYR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNYR is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.31
SNYR Per share dataSNYR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

SNYR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SNYR's earnings are expected to grow with 43.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y55.46%
EPS Next 3Y43.78%

0

5. Dividend

5.1 Amount

SNYR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SYNERGY CHC CORP

NASDAQ:SNYR (5/21/2025, 8:00:02 PM)

After market: 2.1 0 (0%)

2.1

+0.05 (+2.44%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners12.27%
Inst Owner ChangeN/A
Ins Owners8.45%
Ins Owner Change0%
Market Cap18.38M
Analysts82.86
Price Target10.2 (385.71%)
Short Float %8.76%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-96.94%
Valuation
Industry RankSector Rank
PE 7.5
Fwd PE 3.43
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 6.31
EPS(TTM)0.28
EY13.33%
EPS(NY)0.61
Fwd EY29.14%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS3.98
BVpS-1.9
TBVpS-1.93
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13%
ROE N/A
ROCE -689.55%
ROIC 66.57%
ROICexc 74.13%
ROICexgc 77.69%
OM 16.65%
PM (TTM) 6.1%
GM 67.87%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
F-Score3
Asset Turnover2.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 3.96
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.49
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.83
Altman-Z -0.22
F-Score3
WACC10.36%
ROIC/WACC6.43
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.47%
EPS Next Y66.67%
EPS Next 2Y55.46%
EPS Next 3Y43.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%-22.3%
Revenue Next Year36.46%
Revenue Next 2Y25.8%
Revenue Next 3Y20.11%
Revenue Next 5YN/A
EBIT growth 1Y-46.32%
EBIT growth 3YN/A
EBIT growth 5Y26.96%
EBIT Next Year60.22%
EBIT Next 3Y32.67%
EBIT Next 5YN/A
FCF growth 1Y-1239.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1239.06%
OCF growth 3YN/A
OCF growth 5YN/A